Severe immunodeficiency and/or HIV-related conditions prior to the initiation of ART, reflected by low CD4 counts or AIDS diagnosis, were associated with higher rates of discontinuation of first-line ART regimens in several previous reports [2, 17, 19, 20, 22, 29]. This evidence concerns the gene CD4 and immune system disorder.